Z5. COVID-19 Complications, co-infections, and clinical outcomes
Poster Session: COVID-19: Complications, Coinfections and Clinical Outcomes
Essy Mozaffari, PharmD, MPH, MBA
Senior Director
Gilead Sciences
Foster, California, United States
Aastha Chandak, PhD
Senior Manager, Head US Statistics
Certara
New York, New York, United States
Chidinma Chima-Melton, MD
University of California Los Angeles
Los Angeles, California, United States
Andre Kalil, MD, MPH
Professor
University of Nebraska Medical Center, United States
Mark Berry, PhD (he/him/his)
Director, epidemiology
Gilead Sciences, Inc.
Foster City, California, United States
Heng Jiang, MS, MPH
Certara
Paris, Ile-de-France, France
Michele Bartoletti, MD, PhD
Department of Biomedical Sciences, Humanitas University, Pieve Emanuele (Italy); IRCCS Humanitas Research Hospital, Rozzano (Italy)
Rozzano, Lombardia, Italy
Paul LOUBET, MD, PhD (he/him/his)
Infectious Diseases Specialist
CHU de Nîmes
Nimes, Languedoc-Roussillon, France